title: A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation.
authors.affiliation: Department of Cardiac Surgery, Ludwig-Maximilians University of Munich, Germany.
authors.forename: B M
authors.initials: BM
authors.lastname: Meiser
authors.forename: C
authors.initials: C
authors.lastname: Reiter
authors.forename: M
authors.initials: M
authors.lastname: Ebel
authors.forename: P
authors.initials: P
authors.lastname: Uberfuhr
authors.forename: K
authors.initials: K
authors.lastname: Wenke
authors.forename: H
authors.initials: H
authors.lastname: Reichenspurner
authors.forename: E
authors.initials: E
authors.lastname: Rieber
authors.forename: G
authors.initials: G
authors.lastname: Riethmüller
authors.forename: B
authors.initials: B
authors.lastname: Reichart
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D015704:CD4 Antigens / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D001379:Azathioprine